The evolving landscape of combination therapy for pulmonary arterial hypertension

por Griffin, Matthew, Trow, Terence K.
Publicado 2016

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation

por Griffin, Matthew D., Swaminathan, Sundararaman
Publicado 2020

Effects of mesenchymal stromal cells on regulatory T cells: Current understanding and clinical relevance

por Negi, Neema, Griffin, Matthew D.
Publicado 2020

Human Monocyte Subset Distinctions and Function: Insights From Gene Expression Analysis

por Cormican, Sarah, Griffin, Matthew D.
Publicado 2020

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?

por Cormican, Sarah, Griffin, Matthew D.
Publicado 2021

Back from the brink: a mesenchymal stem cell infusion rescues kidney function in acute experimental rhabdomyolysis

por Duffy, Michelle M, Griffin, Matthew D
Publicado 2014

Microbial mechanisms to improve immune checkpoint blockade responsiveness

por Griffin, Matthew E., Hang, Howard C.
Publicado 2022

Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases

por Ou, Qifeng, Power, Rachael, Griffin, Matthew D.
Publicado 2023

Editorial: Insights in renal pharmacology: 2021

por Perico, Norberto, Griffin, Matthew D., Remuzzi, Giuseppe
Publicado 2022

N-arylpyrazole NOD2 agonists promote immune checkpoint inhibitor therapy

por Griffin, Matthew E., Tsukidate, Taku, Hang, Howard C.
Publicado 2023

The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19

por Griffin, Matthew T., Werner, Thomas J., Alavi, Abass, Revheim, Mona-Elisabeth
Publicado 2023

Mesenchymal stem cell effects on T-cell effector pathways

por Duffy, Michelle M, Ritter, Thomas, Ceredig, Rhodri, Griffin, Matthew D
Publicado 2011

Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?

por Lohan, Paul, Treacy, Oliver, Griffin, Matthew D., Ritter, Thomas, Ryan, Aideen E.
Publicado 2017

Translation of peptidoglycan metabolites into immunotherapeutics

por Griffin, Matthew E, Hespen, Charles W, Wang, Yen‐Chih, Hang, Howard C
Publicado 2019

Directing Neuronal Signaling through Cell-Surface Glycan Engineering

por Pulsipher, Abigail, Griffin, Matthew E., Stone, Shannon E., Brown, Joshua M., Hsieh-Wilson, Linda C.
Publicado 2014

The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review

por Elshahat, Sarah, Cockwell, Paul, Maxwell, Alexander P., Griffin, Matthew, O’Brien, Timothy, O’Neill, Ciaran
Publicado 2020

Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?

por Lohan, Paul, Coleman, Cynthia M, Murphy, J Mary, Griffin, Matthew D, Ritter, Thomas, Ryan, Aideen E
Publicado 2014

Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England

por Nguyen, Nga T. Q., Cockwell, Paul, Maxwell, Alexander P., Griffin, Matthew, O’Brien, Timothy, O’Neill, Ciaran
Publicado 2018

Sulfated glycans engage the Ang/Tie pathway to regulate vascular development

por Griffin, Matthew E., Sorum, Alexander W., Miller, Gregory M., Goddard, William A., Hsieh-Wilson, Linda C.
Publicado 2020

Association of Volume Overload With Kidney Function Outcomes Among Patients With Heart Failure With Reduced Ejection Fraction

por McCallum, Wendy, Tighiouart, Hocine, Testani, Jeffrey M., Griffin, Matthew, Konstam, Marvin A., Udelson, James E., Sarnak, Mark J.
Publicado 2020